Share Price and Basic Stock Data
Last Updated: December 9, 2025, 1:30 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Bombay Oxygen Investments Ltd operates within the non-banking financial company (NBFC) sector, a space that has seen fluctuations in performance over recent years. The company’s revenue trajectory has been quite volatile. For instance, sales reported in FY 2023 stood at ₹3 Cr, a significant decline from ₹33 Cr in FY 2022. However, the latest quarter’s sales for June 2024 saw a remarkable rise to ₹29 Cr, indicating some recovery. This upward trend continued into September 2024 with sales of ₹24 Cr. Despite these fluctuations, the company’s overall revenue for the trailing twelve months (TTM) is reported at ₹20 Cr, suggesting that while there are peaks, the consistency remains a challenge. The sales figures reflect an ongoing struggle to maintain a steady revenue stream, which is critical for any financial institution. The historical context shows a mixture of highs and lows, and investors should be cautious about the sustainability of this recent uptick in sales.
Profitability and Efficiency Metrics
Profitability has been a mixed bag for Bombay Oxygen Investments. The operating profit margin (OPM) reported for FY 2024 stood at an impressive 98%, a remarkable figure reflecting the company’s ability to manage its operating expenses effectively. However, this is juxtaposed against a net profit that has shown inconsistency, with FY 2025 net profit declining to ₹18 Cr from ₹58 Cr in FY 2024. The return on equity (ROE) is reported at 3.62%, which, while positive, is relatively low compared to industry standards, indicating that the company is not generating strong returns on shareholder investments. Additionally, the cash conversion cycle, reported at 8 days, appears efficient, suggesting the company can convert its investments into cash quickly. However, the fluctuating net profit, alongside a decline in EPS from ₹3,840.06 in FY 2024 to ₹1,167.06 in FY 2025, raises questions about the sustainability of these profit margins. Investors should weigh these profitability metrics carefully against the backdrop of industry benchmarks.
Balance Sheet Strength and Financial Ratios
The balance sheet of Bombay Oxygen Investments presents a picture of strength, particularly with no reported borrowings. This zero-debt status is a significant advantage, allowing the company to operate without the burden of interest payments. Reserves have steadily increased, reaching ₹482 Cr in FY 2025, providing a cushion for future growth or downturns. The price-to-book value (P/BV) ratio stands at 0.68x, indicating that the stock may be undervalued given its assets. However, the return on capital employed (ROCE) at 3.89% is relatively low, suggesting that while the company has a solid asset base, it might not be utilizing its capital as effectively as it could. Furthermore, the current ratio, reported at 2464.27, indicates exceptional liquidity, which is a positive sign for short-term financial obligations. However, high liquidity could also imply that the company is not fully utilizing its assets for growth, a potential concern for investors looking for aggressive expansion.
Shareholding Pattern and Investor Confidence
The shareholding structure of Bombay Oxygen Investments reveals a strong promoter presence, holding 73.29% of the shares. This significant stake suggests a robust commitment from the founders, which can instill confidence among other investors. However, the minimal participation from domestic institutional investors (DIIs) at 0.06% raises questions about broader institutional interest in the company. The public holding stands at 26.66%, with the number of shareholders reported at 3,039. This indicates a reasonably diversified retail investor base. However, the declining trend in the number of shareholders from previous quarters could hint at waning interest or confidence among retail investors. In a sector where institutional backing often signifies confidence, the lack of DII investment could deter potential investors from taking a position in the stock, despite the strong promoter backing.
Outlook, Risks, and Final Insight
Looking ahead, investors in Bombay Oxygen Investments should be aware of both opportunities and risks. The company’s recent sales recovery is encouraging, but the volatility in revenue and net profit could be a significant red flag. The strong operating margins and zero debt suggest a stable operational framework, yet the low ROE and fluctuating net profits indicate potential inefficiencies that need addressing. Furthermore, the lack of institutional interest may reflect broader market sentiments about the company’s long-term prospects. Investors should consider the company’s ability to capitalize on its asset base and improve its profitability metrics. Risks include the potential for continued revenue volatility and the challenge of attracting institutional investors. Ultimately, the stock presents a mixed bag; while there are strengths in liquidity and operational efficiency, the overall growth trajectory remains uncertain. Investors must weigh the potential for recovery against the backdrop of these risks to make informed decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Bombay Oxygen Investments Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 11.1 Cr. | 1.11 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 9.84 Cr. | 0.98 | 9.18/0.85 | 28.9 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 437 Cr. | 134 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.1 Cr. | 16.5 | 35.2/15.0 | 11.3 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 35.4 Cr. | 78.8 | 176/74.8 | 19.0 | 238 | 1.27 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,225.88 Cr | 441.21 | 53.30 | 522.84 | 0.22% | 15.80% | 8.84% | 8.50 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | -3 | -15 | 17 | 7 | -6 | 22 | 14 | 22 | 13 | 29 | 24 | -19 | -14 |
| Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Operating Profit | -3 | -16 | 17 | 7 | -7 | 21 | 14 | 22 | 12 | 29 | 24 | -19 | -15 |
| OPM % | 98% | 94% | 98% | 97% | 98% | 95% | 99% | 98% | |||||
| Other Income | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -3 | -16 | 17 | 7 | -3 | 21 | 14 | 22 | 13 | 29 | 24 | -18 | -15 |
| Tax % | -2% | -11% | 10% | 10% | -21% | 8% | 13% | 20% | 35% | 6% | 22% | -15% | -16% |
| Net Profit | -3 | -14 | 15 | 6 | -2 | 20 | 12 | 17 | 9 | 27 | 18 | -15 | -12 |
| EPS in Rs | -188.67 | -946.67 | 1,018.67 | 401.33 | -144.00 | 1,304.67 | 790.67 | 1,164.67 | 579.33 | 1,789.33 | 1,230.00 | -1,032.00 | -820.00 |
Last Updated: May 31, 2025, 6:39 am
Below is a detailed analysis of the quarterly data for Bombay Oxygen Investments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is -14.00 Cr.. The value appears strong and on an upward trend. It has increased from -19.00 Cr. (Dec 2024) to -14.00 Cr., marking an increase of 5.00 Cr..
- For Expenses, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Operating Profit, as of Mar 2025, the value is -15.00 Cr.. The value appears strong and on an upward trend. It has increased from -19.00 Cr. (Dec 2024) to -15.00 Cr., marking an increase of 4.00 Cr..
- For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
- For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Dec 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
- For Profit before tax, as of Mar 2025, the value is -15.00 Cr.. The value appears strong and on an upward trend. It has increased from -18.00 Cr. (Dec 2024) to -15.00 Cr., marking an increase of 3.00 Cr..
- For Tax %, as of Mar 2025, the value is -16.00%. The value appears to be improving (decreasing) as expected. It has decreased from -15.00% (Dec 2024) to -16.00%, marking a decrease of 1.00%.
- For Net Profit, as of Mar 2025, the value is -12.00 Cr.. The value appears strong and on an upward trend. It has increased from -15.00 Cr. (Dec 2024) to -12.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is -820.00. The value appears strong and on an upward trend. It has increased from -1,032.00 (Dec 2024) to -820.00, marking an increase of 212.00.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19 | 17 | 18 | 2 | 2 | 11 | 2 | 61 | 33 | 3 | 72 | 20 | 20 |
| Expenses | 24 | 24 | 24 | 7 | 13 | 4 | 25 | 2 | 2 | 2 | 2 | 2 | 2 |
| Operating Profit | -5 | -6 | -7 | -6 | -11 | 8 | -22 | 59 | 31 | 1 | 70 | 19 | 18 |
| OPM % | -25% | -37% | -39% | -383% | -703% | 68% | -900% | 97% | 94% | 36% | 98% | 92% | 92% |
| Other Income | 5 | 20 | 9 | 14 | 13 | -1 | 2 | 7 | 0 | 4 | -0 | 1 | 1 |
| Interest | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 |
| Depreciation | 3 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -3 | 11 | -0 | 8 | 2 | 6 | -20 | 65 | 32 | 5 | 70 | 19 | 19 |
| Tax % | -2% | 33% | -179% | 24% | 25% | -12% | -2% | 11% | 11% | 2% | 18% | 8% | |
| Net Profit | -3 | 8 | 0 | 6 | 1 | 7 | -20 | 58 | 28 | 5 | 58 | 18 | 15 |
| EPS in Rs | -178.67 | 513.33 | 25.33 | 415.33 | 92.00 | 454.00 | -1,314.67 | 3,886.00 | 1,871.33 | 328.00 | 3,840.00 | 1,167.33 | 993.33 |
| Dividend Payout % | -0% | 2% | 39% | 5% | 11% | 2% | -1% | 1% | 1% | 5% | 1% | 3% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 366.67% | -100.00% | -83.33% | 600.00% | -385.71% | 390.00% | -51.72% | -82.14% | 1060.00% | -68.97% |
| Change in YoY Net Profit Growth (%) | 0.00% | -466.67% | 16.67% | 683.33% | -985.71% | 775.71% | -441.72% | -30.42% | 1142.14% | -1128.97% |
Bombay Oxygen Investments Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 52% |
| 3 Years: | -15% |
| TTM: | -74% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 23% |
| 3 Years: | -15% |
| TTM: | -77% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 28% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 9% |
| 3 Years: | 6% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 2:46 pm
Balance Sheet
Last Updated: July 25, 2025, 1:39 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 190 | 198 | 198 | 217 | 209 | 220 | 172 | 301 | 324 | 331 | 461 | 482 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 11 | 13 | 12 | 17 | 6 | 5 | 1 | 10 | 12 | 13 | 31 | 26 |
| Total Liabilities | 203 | 212 | 211 | 236 | 216 | 226 | 175 | 312 | 338 | 346 | 494 | 509 |
| Fixed Assets | 38 | 35 | 32 | 29 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 7 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 68 | 165 | 166 | 196 | 195 | 210 | 158 | 297 | 324 | 333 | 486 | 501 |
| Other Assets | 97 | 12 | 13 | 11 | 12 | 9 | 9 | 8 | 7 | 6 | 1 | 1 |
| Total Assets | 203 | 212 | 211 | 236 | 216 | 226 | 175 | 312 | 338 | 346 | 494 | 509 |
Below is a detailed analysis of the balance sheet data for Bombay Oxygen Investments Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 482.00 Cr.. The value appears strong and on an upward trend. It has increased from 461.00 Cr. (Mar 2024) to 482.00 Cr., marking an increase of 21.00 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing). It has decreased from 31.00 Cr. (Mar 2024) to 26.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 509.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 494.00 Cr. (Mar 2024) to 509.00 Cr., marking an increase of 15.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 7.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 501.00 Cr.. The value appears strong and on an upward trend. It has increased from 486.00 Cr. (Mar 2024) to 501.00 Cr., marking an increase of 15.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For Total Assets, as of Mar 2025, the value is 509.00 Cr.. The value appears strong and on an upward trend. It has increased from 494.00 Cr. (Mar 2024) to 509.00 Cr., marking an increase of 15.00 Cr..
Notably, the Reserves (482.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.00 | -6.00 | -7.00 | -6.00 | -11.00 | 8.00 | -22.00 | 59.00 | 31.00 | 1.00 | 70.00 | 19.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 98 | 84 | 75 | 326 | 44 | 19 | 71 | 3 | 5 | 65 | 2 | 8 |
| Inventory Days | 851 | 584 | 734 | 2 | 5 | |||||||
| Days Payable | 620 | 407 | 195 | 104 | 167 | |||||||
| Cash Conversion Cycle | 98 | 315 | 252 | 864 | -58 | -143 | 71 | 3 | 5 | 65 | 2 | 8 |
| Working Capital Days | 972 | 93 | 86 | 1,472 | -592 | 44 | 748 | 29 | 62 | 828 | 3 | 15 |
| ROCE % | -2% | 8% | -5% | 3% | -2% | 3% | -11% | 25% | 10% | 0% | 18% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Basic EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Diluted EPS (Rs.) | 1167.06 | 3840.06 | 328.31 | 1871.23 | 3885.80 |
| Cash EPS (Rs.) | 1179.98 | 3853.00 | 340.84 | 1883.90 | 3898.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 32204.87 | 30844.34 | 22182.01 | 21723.19 | 20141.89 |
| Dividend / Share (Rs.) | 35.00 | 25.00 | 15.00 | 20.00 | 20.00 |
| Revenue From Operations / Share (Rs.) | 1347.54 | 4722.64 | 174.53 | 2223.11 | 4061.41 |
| PBDIT / Share (Rs.) | 1284.68 | 4694.34 | 347.17 | 2116.54 | 4376.25 |
| PBIT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| PBT / Share (Rs.) | 1271.76 | 4681.40 | 334.63 | 2103.87 | 4363.26 |
| Net Profit / Share (Rs.) | 1167.06 | 3840.06 | 328.30 | 1871.22 | 3885.80 |
| PBDIT Margin (%) | 95.33 | 99.40 | 198.91 | 95.20 | 107.75 |
| PBIT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| PBT Margin (%) | 94.37 | 99.12 | 191.73 | 94.63 | 107.43 |
| Net Profit Margin (%) | 86.60 | 81.31 | 188.10 | 84.17 | 95.67 |
| Return on Networth / Equity (%) | 3.62 | 12.44 | 1.48 | 8.61 | 19.29 |
| Return on Capital Employeed (%) | 3.74 | 14.22 | 1.45 | 9.34 | 20.99 |
| Return On Assets (%) | 3.43 | 11.66 | 1.42 | 8.30 | 18.66 |
| Asset Turnover Ratio (%) | 0.04 | 0.16 | 0.01 | 0.10 | 0.25 |
| Current Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Quick Ratio (X) | 2464.27 | 2283.32 | 1528.36 | 1414.78 | 539.42 |
| Dividend Payout Ratio (NP) (%) | 2.14 | 0.39 | 6.09 | 1.06 | 0.25 |
| Dividend Payout Ratio (CP) (%) | 2.11 | 0.38 | 5.86 | 1.06 | 0.25 |
| Earning Retention Ratio (%) | 97.86 | 99.61 | 93.91 | 98.94 | 99.75 |
| Cash Earning Retention Ratio (%) | 97.89 | 99.62 | 94.14 | 98.94 | 99.75 |
| Enterprise Value (Cr.) | 331.29 | 265.65 | 154.11 | 194.17 | 163.13 |
| EV / Net Operating Revenue (X) | 16.39 | 3.75 | 58.87 | 5.82 | 2.68 |
| EV / EBITDA (X) | 17.19 | 3.77 | 29.59 | 6.12 | 2.48 |
| MarketCap / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| Retention Ratios (%) | 97.85 | 99.60 | 93.90 | 98.93 | 99.74 |
| Price / BV (X) | 0.68 | 0.57 | 0.46 | 0.59 | 0.54 |
| Price / Net Operating Revenue (X) | 16.40 | 3.75 | 58.92 | 5.84 | 2.71 |
| EarningsYield | 0.05 | 0.21 | 0.03 | 0.14 | 0.35 |
After reviewing the key financial ratios for Bombay Oxygen Investments Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 100.00. This value exceeds the healthy maximum of 10. There is no change compared to the previous period (Mar 24) which recorded 100.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Diluted EPS (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For Cash EPS (Rs.), as of Mar 25, the value is 1,179.98. This value is within the healthy range. It has decreased from 3,853.00 (Mar 24) to 1,179.98, marking a decrease of 2,673.02.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 32,204.87. It has increased from 30,844.34 (Mar 24) to 32,204.87, marking an increase of 1,360.53.
- For Dividend / Share (Rs.), as of Mar 25, the value is 35.00. This value exceeds the healthy maximum of 3. It has increased from 25.00 (Mar 24) to 35.00, marking an increase of 10.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,347.54. It has decreased from 4,722.64 (Mar 24) to 1,347.54, marking a decrease of 3,375.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1,284.68. This value is within the healthy range. It has decreased from 4,694.34 (Mar 24) to 1,284.68, marking a decrease of 3,409.66.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 1,271.76. This value is within the healthy range. It has decreased from 4,681.40 (Mar 24) to 1,271.76, marking a decrease of 3,409.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 1,167.06. This value is within the healthy range. It has decreased from 3,840.06 (Mar 24) to 1,167.06, marking a decrease of 2,673.00.
- For PBDIT Margin (%), as of Mar 25, the value is 95.33. This value is within the healthy range. It has decreased from 99.40 (Mar 24) to 95.33, marking a decrease of 4.07.
- For PBIT Margin (%), as of Mar 25, the value is 94.37. This value exceeds the healthy maximum of 20. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For PBT Margin (%), as of Mar 25, the value is 94.37. This value is within the healthy range. It has decreased from 99.12 (Mar 24) to 94.37, marking a decrease of 4.75.
- For Net Profit Margin (%), as of Mar 25, the value is 86.60. This value exceeds the healthy maximum of 10. It has increased from 81.31 (Mar 24) to 86.60, marking an increase of 5.29.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.62. This value is below the healthy minimum of 15. It has decreased from 12.44 (Mar 24) to 3.62, marking a decrease of 8.82.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.74. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to 3.74, marking a decrease of 10.48.
- For Return On Assets (%), as of Mar 25, the value is 3.43. This value is below the healthy minimum of 5. It has decreased from 11.66 (Mar 24) to 3.43, marking a decrease of 8.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has decreased from 0.16 (Mar 24) to 0.04, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 3. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Quick Ratio (X), as of Mar 25, the value is 2,464.27. This value exceeds the healthy maximum of 2. It has increased from 2,283.32 (Mar 24) to 2,464.27, marking an increase of 180.95.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 20. It has increased from 0.39 (Mar 24) to 2.14, marking an increase of 1.75.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.11. This value is below the healthy minimum of 20. It has increased from 0.38 (Mar 24) to 2.11, marking an increase of 1.73.
- For Earning Retention Ratio (%), as of Mar 25, the value is 97.86. This value exceeds the healthy maximum of 70. It has decreased from 99.61 (Mar 24) to 97.86, marking a decrease of 1.75.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.89. This value exceeds the healthy maximum of 70. It has decreased from 99.62 (Mar 24) to 97.89, marking a decrease of 1.73.
- For Enterprise Value (Cr.), as of Mar 25, the value is 331.29. It has increased from 265.65 (Mar 24) to 331.29, marking an increase of 65.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 16.39. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.39, marking an increase of 12.64.
- For EV / EBITDA (X), as of Mar 25, the value is 17.19. This value exceeds the healthy maximum of 15. It has increased from 3.77 (Mar 24) to 17.19, marking an increase of 13.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For Retention Ratios (%), as of Mar 25, the value is 97.85. This value exceeds the healthy maximum of 70. It has decreased from 99.60 (Mar 24) to 97.85, marking a decrease of 1.75.
- For Price / BV (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.68, marking an increase of 0.11.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 16.40. This value exceeds the healthy maximum of 3. It has increased from 3.75 (Mar 24) to 16.40, marking an increase of 12.65.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.21 (Mar 24) to 0.05, marking a decrease of 0.16.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Bombay Oxygen Investments Ltd:
- Net Profit Margin: 86.6%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.74% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.62% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2464.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 53.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 86.6%
Bombay Oxygen Investments Ltd: Intrinsic Value & Share Price Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 22/B, Mittal Tower, Mumbai Maharashtra 400021 | contact@bomoxy.com http://www.bomoxy.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shyam M Ruia | Chairman |
| Ms. Hema Renganathan | Whole Time Director |
| Mr. Vikas M Jain | Director |
| Mr. Mohanbir Singh | Director |
| Mr. Nirmal P Jhunjhunwala | Director |
| Mrs. Aruna K Kanoria | Director |
FAQ
What is the intrinsic value of Bombay Oxygen Investments Ltd?
Bombay Oxygen Investments Ltd's intrinsic value (as of 08 December 2025) is 14925.94 which is 32.24% lower the current market price of 22,029.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 330 Cr. market cap, FY2025-2026 high/low of 32,681/19,552, reserves of ₹482 Cr, and liabilities of 509 Cr.
What is the Market Cap of Bombay Oxygen Investments Ltd?
The Market Cap of Bombay Oxygen Investments Ltd is 330 Cr..
What is the current Stock Price of Bombay Oxygen Investments Ltd as on 08 December 2025?
The current stock price of Bombay Oxygen Investments Ltd as on 08 December 2025 is 22,029.
What is the High / Low of Bombay Oxygen Investments Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Bombay Oxygen Investments Ltd stocks is 32,681/19,552.
What is the Stock P/E of Bombay Oxygen Investments Ltd?
The Stock P/E of Bombay Oxygen Investments Ltd is .
What is the Book Value of Bombay Oxygen Investments Ltd?
The Book Value of Bombay Oxygen Investments Ltd is 34,305.
What is the Dividend Yield of Bombay Oxygen Investments Ltd?
The Dividend Yield of Bombay Oxygen Investments Ltd is 0.16 %.
What is the ROCE of Bombay Oxygen Investments Ltd?
The ROCE of Bombay Oxygen Investments Ltd is 3.89 %.
What is the ROE of Bombay Oxygen Investments Ltd?
The ROE of Bombay Oxygen Investments Ltd is 3.62 %.
What is the Face Value of Bombay Oxygen Investments Ltd?
The Face Value of Bombay Oxygen Investments Ltd is 100.